RxDoctor Payments Data

Thomas Fox, MD

Family Medicine · Prescott, ARNPI 1770583189

Payments from drug & device makers

$1,273in general payments, 2019–2025

Across 82 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$314
  • Lilly USA, LLC$222
  • Boehringer Ingelheim$139
  • Merck$91
  • Pfizer$77
  • Takeda Pharmaceuticals U.S.A., Inc.$75
  • plus $355 from 10 others

What the payments were for

  • Food & beverage$1,273100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,273 in reported general payments places this provider in the 60th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$144,318
Medicare patients
268
Services billed
2,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$111,994
MounjaroTirzepatide71$86,966
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$74,979
JanuviaSitagliptin Phosphate92$72,262
OzempicSemaglutide57$66,545
JardianceEmpagliflozin64$51,991
Breztri AerosphereBudesonide/Glycopyr/Formoterol59$43,304
EntrestoSacubitril/Valsartan35$32,822
XareltoRivaroxaban41$26,811
FarxigaDapagliflozin Propanediol23$20,426
Emgality PenGalcanezumab-Gnlm22$15,853
Trijardy XrEmpaglifloz/Linaglip/Metformin14$15,342
Breo ElliptaFluticasone/Vilanterol21$14,104
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$12,806
SymbicortBudesonide/Formoterol Fumarate34$12,244

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$77$114,852149 claims
GSKTrelegy Ellipta, Breo Ellipta$314$89,083112 claims
Lilly USA, LLCMounjaro$222$86,96671 claims
Boehringer IngelheimJardiance, Trijardy Xr, Tradjenta, Stiolto Respimat$139$81,003102 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$57$75,974116 claims
MerckJanuvia$91$72,26292 claims
Novo NordiskOzempic$58$66,54557 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Prescott

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →